digest
Short Summary
Main recommendation: Be cautious about the stock market's current highs and favor value-oriented, defensive sectors over overheated AI and semiconductor names, while watching oil supply risk from the Strait of Hormuz. The panel argues earnings are strong but partly inflated by private-company markups, and that the AI capex boom will eventually slow, creating a cascading risk.
Key Points
- Earnings look strong on headline numbers (about 15% sales growth and 38% earnings growth with 371 of 500 S&P 500 companies reporting), but David Bahnsen says these are inflated by GAAP markups on private stakes like Anthropic and OpenAI; free cash flow growth is lower, in the teens.
- The market trades at about 22 times earnings, well above historical valuations, which Bahnsen calls frothy and vulnerable in its hot areas, though he sees rotation into value sectors as healthy.
- Lou Basenese calls the oil supply situation the "bigger risk lurking out there," citing a report that Aramco said even if the Strait of Hormuz opened today, replenishing depleted inventories would take up to 18 months at an average rate of 2.1 million barrels per day.
- Bahnsen expects the hyperscalers (Meta, Amazon, Google, Microsoft) to eventually slow AI spending, and warns that a single announced cut without strong AI return-on-investment data could trigger a cascade.
- Yields are a debated concern: Jackie sees the 10-year at 4.6% as troubling, while Bahnsen argues it is not the core problem given roughly 2.5% growth plus 2% inflation, and that the 30-year matters more for home borrowing.
Details Worth Noting
- Concrete instructions: The video gives no step-by-step instructions for investors. Its actionable guidance is directional: favor value and defensive names (Bahnsen says investors would prefer to get more defensive and that better values exist in some sectors), avoid chasing AI-heavy names at expensive multiples, and watch for a hyperscaler spending cut as a signal to exit or reduce exposure. Basenese says he has not been adding Apple on dips because it is too expensive, and has been buying Nvidia and Halozyme (described as a biotech trading at 11 times earnings) as cheap, unloved but growing names.
- Basenese names Eli Lilly as a company he likes; the host cited 48% revenue growth and 33% earnings growth, with Mounjaro sales up 91% (almost $10 billion) and Zepbound around $5 billion, and Basenese argues Lilly's eight year-to-date acquisitions diversify it beyond GLP-1 drugs.
- SpaceX shares fell about 8.5% on AI spending fears despite $7.8 billion in revenue; Starlink is its profit-making segment, while NASA contracts are losing money, and Musk's trillion-dollar revenue target drew skepticism.
- Oil prices cited: WTI around $75 and Brent around $79, with traders awaiting a deal to reopen the Strait of Hormuz.
- Bahnsen notes Nvidia has not made a dollar in 10 months by his description, and that the cap-weighted indexes could eventually catch up with that weakness.
Bottom Line
The panel sees a strong but stretched market where AI-driven optimism and oil supply constraints are the key vulnerabilities, and rotation toward value is the healthier path.
